107 related articles for article (PubMed ID: 16862064)
1. Therapeutic apheresis in the Republic of Macedonia - our five years experience (2000-2004).
Milovanceva-Popovska M; Stojkovski Lj; Grcevska L; Dzikova S; Ristovska V; Gogovska L; Polenakovic M
Prilozi; 2006 Jul; 27(1):37-44. PubMed ID: 16862064
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plasma exchange in Casablanca.
Tazi I; Merimi F; Majd A; Benchemsi N
Transfus Apher Sci; 2008 Aug; 39(1):45-8. PubMed ID: 18583191
[TBL] [Abstract][Full Text] [Related]
3. Plasma exchange in elderly patients.
Basic-Jukic N; Brunetta B; Kes P
Ther Apher Dial; 2010 Apr; 14(2):161-5. PubMed ID: 20438537
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.
Haupt WF; Rosenow F; van der Ven C; Birkmann C
Ther Apher; 2000 Jun; 4(3):195-7. PubMed ID: 10910018
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
[TBL] [Abstract][Full Text] [Related]
7. A survey of therapeutic hemapheresis in Norway year 2000.
Taraldsrud E; Kvalheim G; Jørstad S; Stavem K; Aandahl GS
Transfus Apher Sci; 2003 Apr; 28(2):135-41. PubMed ID: 12679117
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.
Momtaz M; Fayed A; Marzouk K; Shaker A
Ther Apher Dial; 2018 Dec; 22(6):666-673. PubMed ID: 30009495
[TBL] [Abstract][Full Text] [Related]
9. Neurologic indications for therapeutic plasma exchange: an update.
Gwathmey K; Balogun RA; Burns T
J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
[TBL] [Abstract][Full Text] [Related]
10. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Loschiavo C; Grecò M; Polo A; Del Colle R
G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
[TBL] [Abstract][Full Text] [Related]
11. [Relevance of plasma exchange in the treatment of myasthenia gravis: study of 11 cases].
Miladi MI; Feki I; Kammoun H; Elleuch H; Triki C; Gargouri J; Mhiri C
Rev Med Interne; 2008 Feb; 29(2):87-93. PubMed ID: 18035453
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic plasma exchange in a single center: Ibni Sina experience.
Arslan O; Arat M; Tek I; Ayyildiz E; Ilhan O
Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
[TBL] [Abstract][Full Text] [Related]
13. Plasma exchange in neurology patients-experience from single center in Montenegro.
Roganovic M; Erakovic J; Radulovic L; Perunicic S; Milikic D; Vujovic B; Idrizovic Z; Vujovic S; Debeljevic M; Gluscevic S
Ther Apher Dial; 2024 Feb; 28(1):125-130. PubMed ID: 37641163
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of pediatric plasma apheresis in intensive care settings.
Haque A; Sher G; Hoda M; Moiz B
Ther Apher Dial; 2014 Oct; 18(5):497-501. PubMed ID: 24674133
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange.
Kankirawatana S; Huang ST; Marques MB
J Clin Apher; 2007; 22(5):265-9. PubMed ID: 17722047
[TBL] [Abstract][Full Text] [Related]
17. Experience with extracorporeal elimination therapy in myasthenia gravis.
Blaha M; Pitha J; Blaha V; Lanska M; Maly J; Filip S; Brndiar M; Langrova H
Transfus Apher Sci; 2011 Dec; 45(3):251-6. PubMed ID: 22018894
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange in myasthenia gravis complicated with complement activation and urticarial reactions using fresh-frozen plasma as replacement solution.
Rosenkvist J; Berkowicz A; Holsøe E; Sørensen H; Taaning E
Vox Sang; 1984; 46(1):13-8. PubMed ID: 6702139
[TBL] [Abstract][Full Text] [Related]
19. Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective.
Agreda-Vásquez GP; Espinosa-Poblano I; Sánchez-Guerrero SA; Crespo-Solís E; Cabrera-Vásquez S; López-Salmorán J; Barajas J; Peñaloza-Ramírez P; Tirado-Cárdenas N; Velázquez A
J Clin Apher; 2008; 23(5):163-7. PubMed ID: 18819155
[TBL] [Abstract][Full Text] [Related]
20. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
Köhler W; Bucka C; Klingel R
J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
